Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19. Participants in the trial were additionally 71% less likely to catch the common cold ...

As flu season arrives, a new highly infectious COVID-19 variant, Stratus (XFG), is driving a surge in US cases, first ...

Generate Key Takeaways What are the most common COVID-19 symptoms doctors are seeing in025? Read on to find out what to look ...

Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.

Children who tested positive for COVID-19 gained more weight than those who were not diagnosed with COVID-19, according to ...

Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...

Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.

Risk for developing long COVID doubled in kids who got infected with SARS-CoV-2 a second time. Reinfection's greater risk also held up in a range of potential long COVID-related conditions and ...

Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection.

Use of remdesivir and/or nirmatrelvir/ritonavir in patients hospitalised for acute SARS-CoV-2 is tied to fewer deaths during ...

The FDA imposed new restrictions on COVID-19 vaccines, limiting access to the updates shots to people who are at risk for ...

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...